RGT 0.00% 30.0¢ argent biopharma limited

Ann: Annual Report to shareholders, page-17

  1. 176 Posts.
    lightbulb Created with Sketch. 58
    They do have some great medicines, that isn't the issue here really is it. It cost far more than they could handle, and they should have focussed on a couple meds first but it looks like they threw $$ into so many baskets and didn't get to market in time to make it all balance. I hope Mercer keep funding them to get to the point where the drugs they have made successfully reap some benefits and become sort after. That would be a good outcome here... some better news is that the debt we have isn't that significant, so it all depends on sales.... I do hope they can come back strong again... maybe wishful thinking, but they were the first Aus company to establish CBD meds, and I remember how much they had to go through to get the growing licences and jump through the hoops of the governing bodies... at this point, all we can do is pray!
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
0.000(0.00%)
Mkt cap ! $14.52M
Open High Low Value Volume
28.5¢ 30.0¢ 28.5¢ $290 1.008K

Buyers (Bids)

No. Vol. Price($)
1 1456 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 2307 1
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.